
Poll|Articles|November 5, 2025
Poll: Has the Shortage of IV Ativan Impacted Your Practice?
Author(s)Psychiatric Times Editors
Listen
0:00 / 0:00
Key Takeaways
- The shortage of IV Ativan poses challenges in managing psychiatric conditions, particularly catatonia, necessitating alternative treatment strategies.
- Increased incidences of catatonia may occur due to the difficulty in accessing IV Ativan, impacting patient care.
Answer our poll!
Advertisement
Psychiatric Times contributors have noted a challenge in their psychiatric practice: the shortage of intravenous (IV) Ativan.
Has the shortage of IV Ativan impacted your practice?
Have you noticed an increase in catatonia amongst your patients?
If you have noticed an increase in catatonia or a difficulty in accessing IV Ativan, reach out to us at
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Neuropsychiatry in the News: Wearable Technology for Parkinson Disease, Ecopipam for Tourette Syndrome
2
Psyched Perspectives: ADHD in Underrecognized Populations, With Paige Walton, MD
3
Let’s Talk About Drug Testing
4
FDA Feedback Paves Way for New IND Filing for PT00114 in Generalized Anxiety Disorder
5









